| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/1997 | US5665770 Particles carrying a disulfide or reducing thiol |
| 09/09/1997 | US5665769 Ascorbic acid derivatives |
| 09/09/1997 | US5665768 Heteroaryl cycloalkenyl hydroxyureas |
| 09/09/1997 | US5665767 Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same |
| 09/09/1997 | US5665766 Ester of an organic nitrate and a salicylate |
| 09/09/1997 | US5665765 5,6,7,8-tetrahydronaphtho[2,3-b]furan and indano[5,6-b]furan amine compounds |
| 09/09/1997 | US5665761 Infusion of less than 6 hours |
| 09/09/1997 | US5665760 Lyophilized thioxanthenone antitumor agents |
| 09/09/1997 | US5665758 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665757 Nitric oxide synthase inhibitor |
| 09/09/1997 | US5665756 Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
| 09/09/1997 | US5665754 Phosphodiesterase inhibitors, antiinflammatory agents |
| 09/09/1997 | US5665752 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
| 09/09/1997 | US5665751 Pharmaceutical composition for inhibiting the growth of cancers |
| 09/09/1997 | US5665749 For treating inflammation, allergies or cardiovascular diseases in mammals |
| 09/09/1997 | US5665748 Antidiabetic, hypolipidemic agents |
| 09/09/1997 | US5665747 Treating nervous system, psychological, and brain disorders |
| 09/09/1997 | US5665746 Bactericide |
| 09/09/1997 | US5665745 1,2,5-thiadiazole derivatives for treating diseases of central nervous system |
| 09/09/1997 | US5665744 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenzn [cd] indoles |
| 09/09/1997 | US5665743 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665742 Phenolic or cationic germicides or trichlorocarbanilide, carbonate, acid, deodorants |
| 09/09/1997 | US5665741 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases |
| 09/09/1997 | US5665740 Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2,6-dimethyl-pyridine-3,5-dica rboxylate |
| 09/09/1997 | US5665738 Imidazole derivatives and processes for the preparation thereof |
| 09/09/1997 | US5665737 Phosphodiesterase inhibitors |
| 09/09/1997 | US5665736 Antidepressants |
| 09/09/1997 | US5665735 Antiasthmatic, antiallergic, antiinflammatory agents |
| 09/09/1997 | US5665733 3-phenylisoquinol-1(2H)-one derivatives their preparation and their therapeutic application |
| 09/09/1997 | US5665732 Indazole derivatives |
| 09/09/1997 | US5665731 Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal |
| 09/09/1997 | US5665730 Pharmaceutically useful imidazopyridines |
| 09/09/1997 | US5665729 Carbocyclic or heterocyclic fused dihydropyridines |
| 09/09/1997 | US5665728 Administering rapamycin |
| 09/09/1997 | US5665727 Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them |
| 09/09/1997 | US5665725 Piperidine derivatives having anxiolytic effect |
| 09/09/1997 | US5665723 Fibrinogen receptor antagonists |
| 09/09/1997 | US5665722 For treating and/or prevention of psychotic disorders |
| 09/09/1997 | US5665720 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 09/09/1997 | US5665719 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 09/09/1997 | US5665718 Anxiolytic, anticonvulsant, muscle relaxant, sedative, hypnotic agents |
| 09/09/1997 | US5665717 Antibacterial antibiotics |
| 09/09/1997 | US5665716 24-homo vitamin D derivatives, process for their production and pharmaceutical preparations obtained therefrom |
| 09/09/1997 | US5665713 Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| 09/09/1997 | US5665709 Polysubstituted benzimidazole nucleosides as antiviral agents |
| 09/09/1997 | US5665708 Process and antiparasitic intermediates for doramectin |
| 09/09/1997 | US5665707 Treatment for toxoplasmosis with a composition comprising a lincosamide and a spiropiperidyl derivative of rifamycik S |
| 09/09/1997 | US5665706 Nerve growth factor and 2-amino-1,1,3-tricyano-1-propene |
| 09/09/1997 | US5665690 Alicyclic carbonate, terpene, glycol ether or ether acetate |
| 09/09/1997 | US5665593 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 09/09/1997 | US5665580 Antisense oligonucleotide inhibition of papillomavirus transformed cells |
| 09/09/1997 | US5665566 Cloning of enterokinase and method of use |
| 09/09/1997 | US5665561 Administering one or more carbohydrate entities, such as a disaccharide with an n-acetyl-d-glucosamine motif |
| 09/09/1997 | US5665553 Methods for determining and modulating cellular redox potential and genotoxic states |
| 09/09/1997 | US5665392 Administering anemonin pretensis powder and quinine sulfate mixture; side effect reduction |
| 09/09/1997 | US5665390 Sustituted 3,5-diene steroidal compounds |
| 09/09/1997 | US5665389 Insulin, vibrio cholera zonula occludens toxin |
| 09/09/1997 | US5665385 Metal chelidamic acid salt |
| 09/09/1997 | US5665384 Oily capsules of ketoprofen |
| 09/09/1997 | US5665378 Transdermal therapeutic formulation |
| 09/09/1997 | US5665377 Administration system for estradiol |
| 09/09/1997 | US5665375 Reducing fat and cholesterol content by administering l-dopa (dihydroxyphenyl alanine) to poultry |
| 09/09/1997 | US5665373 Prostaglandins, thromboxanes and leukotriene healing agents |
| 09/09/1997 | US5665371 Side effect reduction |
| 09/09/1997 | US5665365 Formulations containing coumarins and the use thereof in the pharmaceutical and cosmetic fields |
| 09/09/1997 | US5665364 Treating skin disorders such as acne |
| 09/09/1997 | US5665348 Polymer of quaternary ammonium alkyl ester of an acrylic acid |
| 09/09/1997 | US5665343 Polymeric platinum complex, preparation thereof, and anticancer agent comprising thereof |
| 09/09/1997 | US5665335 Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 09/09/1997 | CA2136820C Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 09/09/1997 | CA2133966C Ocular androgen therapy in sjogren's syndrome |
| 09/09/1997 | CA2016551C Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them |
| 09/09/1997 | CA2014521C 2-substituted n,n'-ditrimethoxybenzoyl piperazines, a preparation process of the same and therapeutic compositions containing them |
| 09/09/1997 | CA1339452C Enantiomers of citalopram and derivatives thereof |
| 09/09/1997 | CA1339450C Stable oxapenem-3-carboxylic acids |
| 09/09/1997 | CA1339449C Use of a 3s-type compound of a pyrido[1,2,3-de]benzoxazine derivative inthe treatment or prevention of infectious diseases of animals |
| 09/07/1997 | CA2199345A1 Controlled-release composition |
| 09/04/1997 | WO1997032046A1 Method and composition for hair removal |
| 09/04/1997 | WO1997032029A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 09/04/1997 | WO1997032026A1 Adapter molecules for targeting viral particles to cells |
| 09/04/1997 | WO1997032018A2 Hepatitis c virus ribozymes |
| 09/04/1997 | WO1997032008A1 Conjugated linoleic acids for attenuating the allergic response |
| 09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 09/04/1997 | WO1997031948A1 Peptide immunogens for vaccination against and treatment of allergy |
| 09/04/1997 | WO1997031944A1 Fragments of cr1 and their use |
| 09/04/1997 | WO1997031943A1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 09/04/1997 | WO1997031940A1 Isoquinolines useful as analgesics |
| 09/04/1997 | WO1997031939A1 Serine protease inhibitors |
| 09/04/1997 | WO1997031937A1 Serine protease inhibitors |
| 09/04/1997 | WO1997031936A2 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
| 09/04/1997 | WO1997031935A1 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 09/04/1997 | WO1997031933A1 Novel ginseng saponin compounds, process for preparation thereof and anti-tumor agent comprising the same as an active component |
| 09/04/1997 | WO1997031929A1 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs |
| 09/04/1997 | WO1997031923A1 Proton pump inhibitor |
| 09/04/1997 | WO1997031921A1 Immunosuppressive compounds and methods |
| 09/04/1997 | WO1997031920A1 Immunosuppressive compounds and methods |
| 09/04/1997 | WO1997031918A1 Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type |
| 09/04/1997 | WO1997031916A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/04/1997 | WO1997031915A1 NEW PROCESS FOR PREPARING (-)-TRANS-N-p-FLUOROBENZOYLMETHYL-4-(p-FLUOROPHENYL)-3-[[3,4-(METHYLENEDIOXY)PHENOXY]METHYL]-PIPERIDINE |
| 09/04/1997 | WO1997031910A1 Fibrinogen receptor antagonists |